Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis

被引:46
|
作者
Gitiaux, Cyril [1 ,2 ,3 ,4 ]
De Antonio, Marie [5 ,6 ]
Aouizerate, Jessie [5 ]
Gherardi, Romain K. [5 ,7 ]
Guilbert, Thomas [3 ,4 ]
Barnerias, Christine [1 ,2 ]
Bodemer, Christine [8 ]
Brochard-Payet, Karine [9 ]
Quartier, Pierre [10 ]
Musset, Lucile [11 ]
Chazaud, Benedicte [3 ,4 ]
Desguerre, Isabelle [1 ,2 ,3 ,4 ]
Bader-Meunier, Brigitte [10 ]
机构
[1] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pediat Neurol & Pediat Neurophysiol, Paris, France
[2] AP HP, Referral Ctr Neuromuscular Dis Garches Necker Mon, Creteil, France
[3] Paris Descartes Univ, Inst Cochin, Genet & Dev, INSERM U1016, Paris, France
[4] Paris Descartes Univ, Inst Cochin, Genet & Dev, CNRS UMR 8104, Paris, France
[5] Albert Chenevier Henri Mondor Hosp, AP HP, Dept Pathol, Creteil, France
[6] UPMC Univ, Paris Descartes Univ, Ctr Rech Cordeliers, INSERM UMRS1138,Team 22, Paris, France
[7] Paris Est Univ, Mondor Biomed Res Inst, Dept Neurosci, INSERM U955,Team 10, Creteil, France
[8] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Dermatol, Paris, France
[9] CHU Toulouse, Hop Enfants, Dept Pediat Internal Med & Nephrol, Toulouse, France
[10] Paris Descartes Univ, Dept Pediat Immunol Hematol & Rheumatol, Inst Imagine,Necker Hosp, INSERM U1163,AP HP, Paris, France
[11] CHU Pitie Salpetriere, AP HP, Dept Immunol, Paris, France
关键词
juvenile dermatomyositis; vasculopathy; muscle biopsy; prognostic factors; outcome; DISEASE-ACTIVITY; INTERNATIONAL CONSENSUS; PROGNOSTIC-FACTORS; MUSCLE BIOPSY; FOLLOW-UP; SCORE; MULTICENTER; VALIDATION; CHILDREN; ANASARCA;
D O I
10.1093/rheumatology/kev359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Outcome of JDM is highly heterogeneous. Our objective was to determine clinical and muscle biopsy features associated with poor outcome and response to treatment. Methods. Clinical data and muscle biopsy were obtained from a monocentric cohort of 29 patients. Clinical subgroups were defined by latent class model analysis of initial and follow-up parameters. Myopathological features were analysed using validated scores. Capillary loss was determined on reconstructions of transversal sections and assessed in the different age groups to take into account variations of muscle capillarization during post-natal development. Regression models were used to identify initial predictors of therapeutic response. Results. Two distinct homogeneous subgroups of patients were identified according to clinical severity and pathological findings. The smallest group of patients (7/29) presented with severe JDM. Compared with the other group (22/29), patients had more severe muscle weakness at disease onset, low remission rate at 12 months, frequent subcutaneous limb oedema or gastrointestinal (GI) involvement and higher myopathological scores (capillary dropout, perifascicular necrosis/regeneration, fibres with internal myonuclei and fibrosis subscores). Relevance of capillary dropout to JDM severity was substantiated by age based analysis, confirming its major role in JDM pathophysiology. Most of these manifestations could be related to vasculopathy (limb oedema, GI involvement, capillary dropout). Furthermore, Childhood Myositis Assessment Scale <34 with either GI involvement or muscle endomysial fibrosis at disease onset were the best predictors of poor response to treatment. Conclusion. Vasculopathy is prominent in severe JDM. Simple criteria can be used at initial evaluation to identify patients requiring a more intensive therapy.
引用
收藏
页码:470 / 479
页数:10
相关论文
共 49 条
  • [1] Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis
    Aouizerate, Jessie
    De Antonio, Marie
    Bader-Meunier, Brigitte
    Barnerias, Christine
    Bodemer, Christine
    Isapof, Arnaud
    Quartier, Pierre
    Melki, Isabelle
    Charuel, Jean-Luc
    Bassez, Guillaume
    Desguerre, Isabelle
    Gherardi, Romain K.
    Authier, Francois-Jerome
    Gitiaux, Cyril
    RHEUMATOLOGY, 2018, 57 (05) : 873 - 879
  • [2] Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis
    Lin, Ting -Wei
    Hu, Ya-Chiao
    Chiang, Bor-Luen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (02) : 416 - 423
  • [3] Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients
    Mathiesen, P. R.
    Zak, M.
    Herlin, T.
    Nielsen, S. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : 782 - 789
  • [4] Clinical features and disease course of patients with juvenile dermatomyositis
    Gowdie, Peter J.
    Allen, Roger C.
    Kornberg, Andrew J.
    Akikusa, Jonathan D.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (05) : 561 - 567
  • [5] The clinical features of juvenile dermatomyositis: A single-centre cohort
    Cancarini, Paola
    Nozawa, Tomo
    Whitney, Kristi
    Bell-Peter, Audrey
    Marcuz, Jo-Anne
    Taddio, Andrea
    Guo, Jessica
    Dover, Saunya
    Feldman, Brian M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 57
  • [6] Juvenile dermatomyositis associated with anasarca - a clinical case
    Mourao, Ana Filipa
    Pinto, Teresa Laura
    Falcao, Sandra
    Ribeiro, Celia
    Vieira, Helena
    Caetano-Lopes, Joana
    Nero, Patricia
    dos Santos, Fernando Pimentel
    Guimaraes, Jose
    Branco, Jaime Cunha
    ACTA REUMATOLOGICA PORTUGUESA, 2009, 34 (02): : 276 - 280
  • [7] Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis
    Guseinova, D.
    Consolaro, A.
    Trail, L.
    Ferrari, C.
    Pistorio, A.
    Ruperto, N.
    Buoncompagni, A.
    Pilkington, C.
    Maillard, S.
    Oliveira, S. K.
    Sztajnbok, F.
    Cuttica, R.
    Corona, F.
    Katsicas, M. M.
    Russo, R.
    Ferriani, V.
    Burgos-Vargas, R.
    Solis-Vallejo, E.
    Bandeira, M.
    Baca, V.
    Saad-Magalhaes, C.
    Silva, C. A.
    Barcellona, R.
    Breda, L.
    Cimaz, R.
    Gallizzi, R.
    Garozzo, R.
    Martino, S.
    Meini, A.
    Stabile, A.
    Martini, A.
    Ravelli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 117 - 124
  • [8] Clinical features of patients with juvenile and adult dermatomyositis
    Szalmas Orsolya
    Nagy-Vince Melinda
    Danko Katalin
    Farkas Flora
    ORVOSI HETILAP, 2015, 156 (37) : 1491 - 1496
  • [9] Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A
    Kobayashi, I
    Yamada, M
    Takahashi, Y
    Kawamura, N
    Okano, M
    Sakiyama, Y
    Kobayashi, K
    RHEUMATOLOGY, 2003, 42 (02) : 371 - 374
  • [10] Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review
    Goncalves Junior, Jucier
    Shinjo, Samuel Katsuyuki
    CURRENT RHEUMATOLOGY REPORTS, 2024, 26 (02) : 53 - 68